PFIZER REPORTS THIRD-QUARTER 2019 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
- Needham Starts NeoVolta (NEOV) at Buy
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- SanDisk stock target lifted by Citi on continued demand strength
Pfizer (PFE) Tops Q3 EPS by 13c, Raises FY Guidance
October 29, 2019 6:46 AM EDTPfizer (NYSE: PFE) reported Q3 EPS of $0.75, $0.13 better than the analyst estimate of $0.62. Revenue for the quarter came in at $12.7 billion versus the consensus estimate of $12.26 billion.
GUIDANCE:
Pfizer sees FY2019 EPS of $2.94-$3.00, versus the consensus of $2.82. Pfizer sees... More
